208 related articles for article (PubMed ID: 38186995)
1. Risk factors for male breast cancer.
Fentiman IS
Am J Transl Res; 2023; 15(12):6918-6925. PubMed ID: 38186995
[TBL] [Abstract][Full Text] [Related]
2. Male breast cancer: a review.
Fentiman I
Ecancermedicalscience; 2009; 3():140. PubMed ID: 22276005
[TBL] [Abstract][Full Text] [Related]
3. Male breast cancer is not congruent with the female disease.
Fentiman IS
Crit Rev Oncol Hematol; 2016 May; 101():119-24. PubMed ID: 26989051
[TBL] [Abstract][Full Text] [Related]
4. The endocrinology of male breast cancer.
Fentiman IS
Endocr Relat Cancer; 2018 Jun; 25(6):R365-R373. PubMed ID: 29752333
[TBL] [Abstract][Full Text] [Related]
5. Male breast cancer.
Fentiman IS; Fourquet A; Hortobagyi GN
Lancet; 2006 Feb; 367(9510):595-604. PubMed ID: 16488803
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the male breast and Klinefelter's syndrome: is there an association?
Evans DB; Crichlow RW
CA Cancer J Clin; 1987; 37(4):246-51. PubMed ID: 3111653
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention for high-risk women: tamoxifen and beyond.
Fabian CJ; Kimler BF
Breast J; 2001; 7(5):311-20. PubMed ID: 11906441
[TBL] [Abstract][Full Text] [Related]
8. Synchronous bilateral breast cancer in a patient with Klinefelter's syndrome.
Hoque HM; Kothari A; Hamed H; Fentiman IS
Int J Gen Med; 2010 Apr; 3():19-21. PubMed ID: 20463819
[TBL] [Abstract][Full Text] [Related]
9. [What is the interest of Klinefelter's syndrome for (child) psychiatrists?].
Kebers F; Janvier S; Colin A; Legros JJ; Ansseau M
Encephale; 2002; 28(3 Pt 1):260-5. PubMed ID: 12091788
[TBL] [Abstract][Full Text] [Related]
10. Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk.
Strojnik K; Krajc M; Dragos VS; Stegel V; Novakovic S; Blatnik A
Breast Cancer Res Treat; 2021 Aug; 188(3):811-820. PubMed ID: 33891299
[TBL] [Abstract][Full Text] [Related]
11. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
Deb S; Jene N; ; Fox SB
BMC Cancer; 2012 Nov; 12():510. PubMed ID: 23146383
[TBL] [Abstract][Full Text] [Related]
12. BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.
Falchetti M; Lupi R; Rizzolo P; Ceccarelli K; Zanna I; Calò V; Tommasi S; Masala G; Paradiso A; Gulino A; Giannini G; Russo A; Palli D; Ottini L
Breast Cancer Res Treat; 2008 Jul; 110(1):161-7. PubMed ID: 17661168
[TBL] [Abstract][Full Text] [Related]
13. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome.
Scofield RH; Bruner GR; Namjou B; Kimberly RP; Ramsey-Goldman R; Petri M; Reveille JD; Alarcón GS; Vilá LM; Reid J; Harris B; Li S; Kelly JA; Harley JB
Arthritis Rheum; 2008 Aug; 58(8):2511-7. PubMed ID: 18668569
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.
King MC; Wieand S; Hale K; Lee M; Walsh T; Owens K; Tait J; Ford L; Dunn BK; Costantino J; Wickerham L; Wolmark N; Fisher B;
JAMA; 2001 Nov; 286(18):2251-6. PubMed ID: 11710890
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
Phillips KA; Milne RL; Rookus MA; Daly MB; Antoniou AC; Peock S; Frost D; Easton DF; Ellis S; Friedlander ML; Buys SS; Andrieu N; Noguès C; Stoppa-Lyonnet D; Bonadona V; Pujol P; McLachlan SA; John EM; Hooning MJ; Seynaeve C; Tollenaar RA; Goldgar DE; Terry MB; Caldes T; Weideman PC; Andrulis IL; Singer CF; Birch K; Simard J; Southey MC; Olsson HL; Jakubowska A; Olah E; Gerdes AM; Foretova L; Hopper JL
J Clin Oncol; 2013 Sep; 31(25):3091-9. PubMed ID: 23918944
[TBL] [Abstract][Full Text] [Related]
16. Screening of endocrine organ-specific humoral autoimmunity in 47,XXY Klinefelter's syndrome reveals a significant increase in diabetes-specific immunoreactivity in comparison with healthy control men.
Panimolle F; Tiberti C; Granato S; Semeraro A; Gianfrilli D; Anzuini A; Lenzi A; Radicioni A
Endocrine; 2016 Apr; 52(1):157-64. PubMed ID: 25935328
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
Narod SA; Brunet JS; Ghadirian P; Robson M; Heimdal K; Neuhausen SL; Stoppa-Lyonnet D; Lerman C; Pasini B; de los Rios P; Weber B; Lynch H;
Lancet; 2000 Dec; 356(9245):1876-81. PubMed ID: 11130383
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Kotsopoulos J; Gronwald J; Huzarski T; Aeilts A; Randall Armel S; Karlan B; Singer CF; Eisen A; Tung N; Olopade O; Bordeleau L; Eng C; Foulkes WD; Neuhausen SL; Cullinane CA; Pal T; Fruscio R; Lubinski J; Metcalfe K; Sun P; Narod SA;
Breast Cancer Res Treat; 2023 Sep; 201(2):257-264. PubMed ID: 37432545
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
Reding KW; Bernstein JL; Langholz BM; Bernstein L; Haile RW; Begg CB; Lynch CF; Concannon P; Borg A; Teraoka SN; Törngren T; Diep A; Xue S; Bertelsen L; Liang X; Reiner AS; Capanu M; Malone KE;
Breast Cancer Res Treat; 2010 Sep; 123(2):491-8. PubMed ID: 20135344
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians.
Peshkin BN; Isaacs C; Finch C; Kent S; Schwartz MD
J Clin Oncol; 2003 Dec; 21(23):4322-8. PubMed ID: 14645421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
